Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
"Importin 5 pseudogene 1" refers to a pseudogene, meaning it is a genetic element similar in sequence to the true "importin 5" gene but generally considered nonfunctional and does not encode a functional protein. Pseudogenes do not have known therapeutic relevance and are not considered drug targets. The functional, protein-coding version is Importin 5 (IPO5), which is involved in nuclear import and is a member of the importin beta family, but IPO5P1 itself does not appear to have any established biological function or disease relevance. IPO5 encodes a functional nuclear import receptor and is scientifically and clinically relevant, but "IPO5P1/Importin 5 pseudogene 1" is a pseudogene, with no evidence of a therapeutic or biological role. There is no evidence it acts as a receptor, enzyme, transporter, or transcription factor, and it is not described in canonical target databases or disease literature as a target or biomarker. Alias "importin 5 pseudogene 1" confirms its status as a pseudogene. No mechanism of action, interacting drugs, disease involvement, or safety concerns are described for IPO5P1 in the scientific literature. "Importin 5 pseudogene 1" (IPO5P1) is not an active molecular target; it is a nonfunctional pseudogene, and there appears to be a misunderstanding if it is referenced as a receptor or therapeutic target. The canonical active protein would instead be "Importin 5" (IPO5).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Importin 5 pseudogene 1 (IPO5P1).